Philadelphia, PA

Mispro Philly is Now Open

Take the first step

Schedule a tour of this facility

Mispro virtual tour

Experience our full-service contract vivarium facilities

Why Mispro?

Discover how to conduct and control your own science

Stay up to date with our Philly uCity Opening

Philadelphia biotech & biopharma companies now have access to turnkey vivarium rental space for preclinical in vivo drug development studies where you can focus on science while we take care of the rest.

Experience Mispro Vivarium Research Facilities

Take the first step

Get connected today!

Why Mispro

Space to fit your needs

Procedure rooms (private/shared)
Holding rooms (private/shared)
Necropsy and Quarantine rooms
In-room Class II biosafety cabinets (BSCs)
State-of-the-art IVC caging racks
AAALAC-accredited vivarium facilities
24/7 year-round key-card access

‍

Vivarium services for your research

Vivarium management
Veterinary care & animal husbandry
Staffing, maintenance & sanitization
In vivo technical services support & training
IACUC oversight and protocol assistance

‍

Amenities and technology

Fully-equipped conference room
Cyber Cafe kitchen and break area
Easy access from public transport, highways, or walking
Leading instrument and technology such as Transnetyx and Somark

‍

Expert animal care & compliance oversight

Mispro is an AAALAC-accredited organization committed to providing best-in-class laboratory animal services and regulatory compliance oversight for your preclinical research. To ensure safety and compliance at all times in our research facilities, we require that every study conducted in our vivarium facilities is approved by our in-house Institutional Animal Care and Use Committee (IACUC). Mispro strictly follows regulatory guidelines for the ethical and humane treatment of research animals.

Advancing preclinical development in key life science hubs

Our state-of-the-art research environments focus on quality, compliance, and consistency, leading to more accurate data and faster results. Take the first step in de-risking your preclinical studies.

Request Info

Learn More
‍

Download our latest whitepaper